The funding round was led by Wellington Management. The company sees its approach as a break from the industry's "disproportionate" focus on dialysis, which is used to treat people with kidney failure.
By Frank Vinluan Wednesday, February 23, 2022 7:37 PM
A Kodiak Sciences drug failed to beat a Regeneron Pharmaceuticals product in a key test in the wet form of age-related macular degeneration. The biotech says the failure is due to a subset of undertreated patients, but the results raise the stakes for the drug, its lead product candidate, in other eye diseases.
By Subha Airan-Javia, MD Wednesday, February 23, 2022 6:20 PM
Even with EHRs, notes are still written down on paper and some critical communication never happens between clinicians. To reduce medical errors, we need to keep improving our systems for collaboration.
By Michael Schroeder Wednesday, February 23, 2022 5:16 PM
In its second report evaluating whether hospitals are with complying with the price transparency rule that went into effect Jan. 1, 2021, PatientRightsAdvocate.org found compliance to be still very low with none of the hospitals at the nation's largest hospital system posting prices online.
By Arundhati Parmar Wednesday, February 23, 2022 4:07 PM
Omada got funds from two new investors – Fidelity Management & Research Company and aMoon as well as existing ones. Verily's Onduo is bringing its virtual diabetes management platform to an integrated care delivery and health plan that has 6 million members in Pennsylvania, West Virginia, Delaware, and New York.
By Frank Vinluan Wednesday, February 23, 2022 12:53 PM
Sanofi and GlaxoSmithKline weathered clinical trial delays for their Covid-19 vaccine, but the partners now have data to support filings seeking regulatory authorizations. Key features of the vaccine may be able to persuade the vaccine hesitant; it may also be well-suited for use as a booster.
No comments